CHARACTERIZATION OF [H-3] CP-96,501 AS A SELECTIVE RADIOLIGAND FOR THE SEROTONIN 5-HT1B RECEPTOR - BINDING-STUDIES IN RAT-BRAIN MEMBRANES

被引:21
作者
KOE, BK
LEBEL, LA
FOX, CB
MACOR, JE
机构
[1] Department of Neuroscience, Central Research Division, Pfizer Inc., Groton, Connecticut
关键词
H-3]CP-96,501 BINDING; SEROTONIN 5-HT1B RECEPTOR; SEROTONIN 5-HT1B AGONISTS; TETRAHYDROPYRIDYLINDOLES;
D O I
10.1111/j.1471-4159.1992.tb11338.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
3-(1,2,5,6-Tetrahydro-4-pyridyl)-5-n-propoxyindole (CP-96,501) was found to be a more selective ligand at the serotonin 5-HT1B receptor than the commonly used 5-HT1B agonist, 3-(1,2,5,6-tetrahydro-4-pyridyl)-5-methoxyindole (RU 24969). In rat brain membranes, the tritiated derivative, [H-3]CP-96,501, was found to bind with a high affinity (K(D), 0.21 nM) to a single binding site (n(H), 1.0). The receptor density of this site (B(max), 72 fmol/mg of protein) matched that of the 5-HT1B receptor determined with [H-3]5-HT. Competition curves of 16 serotonergic compounds in [H-3]CP-96,501 binding also indicated a single binding site. The rank order of their binding affinities with this new radioligand showed a high degree of correlation with their affinities at the 5-HT1B receptor determined with [H-3]5-HT or [I-125]iodocyanopindolol. Serotonergic compounds displayed competitive inhibition of [H-3]CP-96,501 binding. In the presence of 5'-guanylylimidodiphosphate [Gpp(NH)p], [H-3]CP-96,501 binding was reduced, while the potency of CP-96,501 to displace [I-125]iodocyanopindolol binding was also decreased. These findings are consistent with the agonist nature of CP-96,501. The results of this study suggest that [H-3]CP-96,501 is a useful agonist radioligand for the 5-HT1B receptor.
引用
收藏
页码:1268 / 1276
页数:9
相关论文
共 41 条
[1]  
Bennett J., 1985, NEUROTRANSMITTER REC, V2nd, P61
[2]  
BEVAN P, 1989, BEHAVIORAL PHARM 5HT
[3]   5-HT1B RECEPTORS ARE NEGATIVELY COUPLED WITH ADENYLATE-CYCLASE IN RAT SUBSTANTIA NIGRA [J].
BOUHELAL, R ;
SMOUNYA, L ;
BOCKAERT, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 151 (02) :189-196
[4]  
FOZARD J, 1989, PERIPHERAL ACTIONS 5
[5]  
GERSHON MD, 1990, NEUROPSYCHOPHARMACOL, V3, P385
[6]   SEROTONIN RECEPTORS - CLINICAL IMPLICATIONS [J].
GLENNON, RA .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 1990, 14 (01) :35-47
[7]   [I-125]-1-(2,5-DIMETHOXY-4-IODOPHENYL)-2-AMINOPROPANE - AN IODINATED RADIOLIGAND THAT SPECIFICALLY LABELS THE AGONIST HIGH-AFFINITY STATE OF 5-HT2 SEROTONIN RECEPTORS [J].
GLENNON, RA ;
SEGGEL, MR ;
SOINE, WH ;
HERRICKDAVIS, K ;
LYON, RA ;
TITELER, M .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (01) :5-7
[8]   SYNTHESIS OF 3-(1,2,3,6-TETRAHYDRO PYRIDIN-4-YL) 1H-INDOLES AND STUDY OF THEIR SEROTONINERGIC AND ANTIDOPAMINERGIC PROPERTIES [J].
GUILLAUME, J ;
DUMONT, C ;
LAURENT, J ;
NEDELEC, L .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1987, 22 (01) :33-43
[9]  
HAMBLIN MW, 1987, J PHARMACOL EXP THER, V243, P989
[10]  
HAMON M, 1990, NEUROPSYCHOPHARMACOL, V3, P349